New targeted therapy could bring relief to people with lichen planus
Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...
Medscape10d
Long-term interferon-gamma therapy for patients with chronic granulomatous disease.
Infections are dramatically reduced by prophylaxis with antibiotics, antifungals, and interferon- gamma (IFN ... clinical safety and efficacy of IFN-gamma therapy. Patients received IFN-gamma ...
Safeguarding intestinal stem cells during aging through balanced signaling
A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a ...
technologynetworks12d
Targeted Therapy Shows Effectiveness in Skin Disease Patients
Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...
News Medical on MSN1d
New insight into gut stem cell aging
A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a delicate balance between interferon-gamma (IFN-γ) and extracellular ...
Medscape5d
Improvement of Blood Inflammatory Marker Levels in Patients With Hypothyroidism Under Levothyroxine Treatment
The aim of this study was to investigate the effect of levothyroxine replacement therapy on biomarkers ... interleukin 1 (IL-1), IL-6, IL-10, interferon gamma (INF-γ), tumor necrosis factor ...
HDAC Inhibitor Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies by DelveInsight
DelveInsight’s, “HDAC Inhibitor Pipeline Insight” report provides comprehensive insights about 40+ companies and 50+ pipeline ...
Zacks Small Cap Research on MSN17d
IMNN: Gearing Up to Initiate Phase 3 Ovarian Cancer Trial in 1Q25…
IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...